XMax (XMAX) risk factors, FY2024 10-K

XMax's FY2024 10-K, filed Mar 31, 2025, lists 32 risk factors in 2 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
322 groups
Section length
10k wordsItem 1A

XMax's biggest risks in the FY2024 10-K

  • XMax relies on foreign suppliers in Asia, creating supply chain, tariff, and geopolitical vulnerabilities with China.
  • The company faces Nasdaq delisting risks due to failing minimum bid price and stockholders equity requirements.
  • A deliberate strategic shift to drop low-margin customers and products threatens near-term sales and earnings.

The risks most specific to XMax

  • Risks Related to Our Business

    We historically have derived a substantial part of our sales from a limited number of customers. If we lose any of these customers, or any of these customers reduce the amount of business they do with us, our sales may be adversely affected

    One customer accounted for 18% of our total sales in 2023, creating concentration risk if key purchasers reduce orders.

  • Risks Related to Our Business

    Our decision to move away from low margin products and to eliminate customers who generate low margin sales and that have slow payment histories could result in a decrease in our future sales and earnings

    Our intentional transition away from low-margin products and slow-paying clients could decrease future sales and earnings.

  • Risks Related to Our Business

    We may lose U.S. market share due to competition and our dependence on production facilities located outside the U.S., which would result in a decrease in our future sales and earnings

    We depend on production facilities outside the U.S. for our Diamond Sofa brand, exposing us to market share losses.

  • Risks Related to Our Business

    Our dependence on foreign suppliers and our increased global operations subject us to a variety of risks and uncertainties that could impact our operations and financial results

    The majority of our products are purchased from foreign suppliers in Asia, making us vulnerable to foreign currency fluctuations.

  • Risks Related to Our Business

    We depend on vendors and suppliers outside the U.S. Our business has been and could in the future continue to be affected by increase of tariff associated with our products sourced by foreign countries

    U.S. and China trade disputes and the imposition of tariffs on Chinese imports negatively affect our sourced products.

  • Risks Related to Our Business

    Our ongoing investment in new products is inherently risky, and could disrupt our current operations

    Our new product expansion into high-end physiotherapeutic jade mats in Malaysia and Southeast Asia is inherently risky.

  • Risks Related to Our Business

    If relations between the U.S. and China worsen, our business could be adversely affected as we have to find new suppliers and manufacturers out of China

    Worsening political and trade relations between the U.S. and China could force us to find new non-China suppliers.

  • Risks Related to Our Securities

    Our shares may be delisted under the HFCA Act and related regulations if the PCAOB is unable to inspect our auditor, and the delisting of our shares, or the threat of their being delisted, may materially and adversely affect the value of your investment

    The Holding Foreign Companies Accountable Act threatens our shares with delisting if the PCAOB cannot inspect our auditor.

  • Risks Related to Our Securities

    The Company intends to continue actively monitoring the bid price for its common stock between now and the expiration of the Compliance Period and will consider all available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement

    We received a Nasdaq notice stating we failed to meet the $2,500,000 minimum stockholders equity requirement for continued listing.

All 32 risk factors

Headings as the filing states them, in filing order.

Risks Related to Our Business

  1. 01Changes in economic conditions in the industries and markets served by our customers could adversely affect demand for our products
  2. 02We historically have derived a substantial part of our sales from a limited number of customers. If we lose any of these customers, or any of these customers reduce the amount of business they do with us, our sales may be adversely affected
  3. 03Our decision to move away from low margin products and to eliminate customers who generate low margin sales and that have slow payment histories could result in a decrease in our future sales and earnings
  4. 04If we lose our key personnel, or are unable to attract and retain additional qualified personnel, the quality of our services may decline and our business may be adversely affected
  5. 05We may not be able to keep pace with competition in our industry, which could adversely affect our market share and result in a decrease in our future sales and earnings
  6. 06We may lose U.S. market share due to competition and our dependence on production facilities located outside the U.S., which would result in a decrease in our future sales and earnings
  7. 07Failure to anticipate or timely respond to changes in fashion and consumer preferences could adversely impact our business
  8. 08If we are unable to manage our growth, we may not be profitable
  9. 09We may need additional capital to execute our business plan and fund operations and may not be able to obtain such capital on acceptable terms or at all
  10. 10We may experience material disruptions to our ability to acquire sufficient inventory from third-party suppliers that could result in material delays, quality control issues, increased costs and loss of business opportunities, which may negatively impact our sales and financial results
  11. 11Our dependence on foreign suppliers and our increased global operations subject us to a variety of risks and uncertainties that could impact our operations and financial results
  12. 12A delay in getting non-U.S.-sourced products through port operations and customs in a timely manner could result in reduced sales, canceled sales orders and unanticipated inventory accumulation
  13. 13We depend on vendors and suppliers outside the U.S. Our business has been and could in the future continue to be affected by increase of tariff associated with our products sourced by foreign countries
  14. 14We are subject to warranty claims for our products, which could result in unexpected expense
  15. 15We are subject to periodic litigation, product liability risk and other regulatory proceedings, which could result in unexpected expense of time and resources
  16. 16We may not be able to protect our product designs and other proprietary rights adequately, which could adversely affect our competitive position and reduce the value of our products and brands, and litigation to protect our intellectual property rights may be costly
  17. 17We, or the owners of the intellectual property rights licensed to us, may be subject to claims that we or such licensors have infringed the proprietary rights of others, which could require us and our licensors to obtain a license or change designs
  18. 18As a public company with substantial operations, we incur significant legal, accounting and other expenses. The costs of preparing and filing annual, quarterly and current reports, proxy statements and other information with the SEC and furnishing audited reports to shareholders is time-consuming and costly
  19. 19Our ongoing investment in new products is inherently risky, and could disrupt our current operations
  20. 20Cybersecurity incidents could disrupt business operations, result in the loss of critical and confidential information and adversely impact our reputation and results of operations
  21. 21If we fail to establish and maintain an effective system of internal controls, we may not be able to report our financial results accurately. Any inability to report and file our financial results accurately and timely could harm our business and adversely affect the trading price of our common stock
  22. 22We are a holding company that depends on cash flow from our wholly owned subsidiaries to meet our obligations, and any inability of our subsidiaries to pay us dividends or make other payments to us when needed could disrupt or have a negative impact on our business
  23. 23If relations between the U.S. and China worsen, our business could be adversely affected as we have to find new suppliers and manufacturers out of China
  24. 24Our compliance with the Foreign Corrupt Practices Act may put us at a competitive disadvantage, while our failure to comply with the Foreign Corrupt Practices Act may result in substantial penalties

Risks Related to Our Securities

  1. 25Our shares may be delisted under the HFCA Act and related regulations if the PCAOB is unable to inspect our auditor, and the delisting of our shares, or the threat of their being delisted, may materially and adversely affect the value of your investment
  2. 26The market price for our common stock may be volatile, which could make it more difficult or impossible for an investor to sell our common stock for a positive return on their investment
  3. 27Shares of our common stock lack a significant trading market, which could make it more difficult for an investor to sell our common stock
  4. 28If we fail to continue to meet the listing standards of NASDAQ, our common stock may be delisted, which could have a material adverse effect on the liquidity of our common stock
  5. 29The Company intends to continue actively monitoring the bid price for its common stock between now and the expiration of the Compliance Period and will consider all available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement
  6. 30We may issue additional shares of our common stock or debt securities to raise capital or complete acquisitions, which would reduce the equity interest of our shareholders
  7. 31We do not expect to pay dividends in the foreseeable future. Any return on investment may be limited to the value of our common stock
  8. 32Short sellers of our stock may be manipulative and may drive down the market price of our common stock

Other XMax 10-Ks

  • FY2025 10-K risk factors
    27 risks5 dropped8 reworded

    XMax expanded its authorized common stock from 250 million to 5 billion shares, highlighting dilution and capital raising risks.

    Filed Apr 15, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.